Jason Kolbert
Stock Analyst at D. Boral Capital
(2.02)
# 2,943
Out of 4,761 analysts
266
Total ratings
36.5%
Success rate
-7.52%
Average return
Main Sectors:
Stocks Rated by Jason Kolbert
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNOV MediciNova | Maintains: Buy | $9 | $1.83 | +391.80% | 3 | Feb 21, 2025 | |
| IMUX Immunic | Maintains: Buy | $17 | $1.27 | +1,238.58% | 6 | Feb 20, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $25 | $10.08 | +148.02% | 11 | Feb 20, 2025 | |
| OMER Omeros | Maintains: Buy | $36 | $9.18 | +292.16% | 3 | Feb 20, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $25 → $22 | $9.75 | +125.64% | 4 | Feb 20, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $20 | $1.70 | +1,076.47% | 7 | Feb 20, 2025 | |
| IBRX ImmunityBio | Maintains: Buy | $30 | $3.42 | +777.19% | 11 | Feb 19, 2025 | |
| IMNN Imunon | Maintains: Buy | $29 | $0.92 | +3,055.60% | 8 | Feb 19, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $10 | $2.28 | +338.60% | 4 | Feb 19, 2025 | |
| KAPA Kairos Pharma | Maintains: Buy | $9 | $1.25 | +620.00% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $1.80 | +455.56% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.48 | +981.08% | 1 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.80 | +400.00% | 9 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 | $3.47 | +303.46% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $8.35 | +450.90% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $2 | $0.68 | +195.86% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $1.06 | +371.70% | 5 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.13 | - | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $1.00 | +1,200.00% | 7 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.55 | +804.98% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $6.41 | +134.01% | 4 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 | $4.43 | +419.19% | 8 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $1.40 | +757.14% | 5 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.77 | +408.47% | 6 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 | $1.67 | +977.84% | 10 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 | $2.28 | +1,259.65% | 7 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.33 | +6,570.71% | 1 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $3.08 | +224.68% | 8 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $10.13 | +48.08% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $3.54 | +606.21% | 8 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $1.57 | +855.41% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $0.45 | +2,565.48% | 8 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $0.81 | +1,005.65% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.16 | +417.24% | 3 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $128 → $16 | $3.46 | +362.43% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $1.15 | +769.57% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.13 | +187.54% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 | $2.92 | +995.89% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $4.60 | +356.52% | 9 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $6.30 | +265.08% | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 | $1.13 | +1,322.22% | 6 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.17 | +412.82% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9,600 | $9.17 | +104,589.20% | 1 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.45 | - | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16,002 → $45,990 | $2.04 | +2,254,311.76% | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.39 | +30,426.58% | 1 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.12 | +4,908.35% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.31 | - | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.09 | - | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.47 | - | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.53 | - | 1 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $40 | $0.77 | +5,065.96% | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $32 | $1.07 | +2,890.65% | 8 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $720 → $480 | $2.43 | +19,653.09% | 2 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Sell | n/a | $5.76 | - | 4 | Jun 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.40 | - | 2 | Mar 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $135 | $1.73 | +7,703.47% | 1 | Aug 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.59 | - | 2 | May 18, 2017 |
MediciNova
Feb 21, 2025
Maintains: Buy
Price Target: $9
Current: $1.83
Upside: +391.80%
Immunic
Feb 20, 2025
Maintains: Buy
Price Target: $17
Current: $1.27
Upside: +1,238.58%
UroGen Pharma
Feb 20, 2025
Maintains: Buy
Price Target: $25
Current: $10.08
Upside: +148.02%
Omeros
Feb 20, 2025
Maintains: Buy
Price Target: $36
Current: $9.18
Upside: +292.16%
AVITA Medical
Feb 20, 2025
Maintains: Buy
Price Target: $25 → $22
Current: $9.75
Upside: +125.64%
OS Therapies
Feb 20, 2025
Maintains: Buy
Price Target: $20
Current: $1.70
Upside: +1,076.47%
ImmunityBio
Feb 19, 2025
Maintains: Buy
Price Target: $30
Current: $3.42
Upside: +777.19%
Imunon
Feb 19, 2025
Maintains: Buy
Price Target: $29
Current: $0.92
Upside: +3,055.60%
CervoMed
Feb 19, 2025
Upgrades: Buy
Price Target: $10
Current: $2.28
Upside: +338.60%
Kairos Pharma
Feb 18, 2025
Maintains: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
Feb 18, 2025
Maintains: Buy
Price Target: $10
Current: $1.80
Upside: +455.56%
Feb 18, 2025
Initiates: Buy
Price Target: $16
Current: $1.48
Upside: +981.08%
Feb 18, 2025
Maintains: Buy
Price Target: $9
Current: $1.80
Upside: +400.00%
Feb 12, 2025
Maintains: Buy
Price Target: $14
Current: $3.47
Upside: +303.46%
Feb 12, 2025
Maintains: Buy
Price Target: $46
Current: $8.35
Upside: +450.90%
Feb 11, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.68
Upside: +195.86%
Feb 11, 2025
Maintains: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
Feb 10, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.13
Upside: -
Feb 7, 2025
Maintains: Buy
Price Target: $13
Current: $1.00
Upside: +1,200.00%
Feb 6, 2025
Maintains: Buy
Price Target: $5
Current: $0.55
Upside: +804.98%
Feb 6, 2025
Maintains: Buy
Price Target: $15
Current: $6.41
Upside: +134.01%
Feb 6, 2025
Maintains: Buy
Price Target: $23
Current: $4.43
Upside: +419.19%
Feb 5, 2025
Maintains: Buy
Price Target: $12
Current: $1.40
Upside: +757.14%
Feb 3, 2025
Maintains: Buy
Price Target: $9
Current: $1.77
Upside: +408.47%
Jan 31, 2025
Maintains: Buy
Price Target: $18
Current: $1.67
Upside: +977.84%
Jan 28, 2025
Maintains: Buy
Price Target: $31
Current: $2.28
Upside: +1,259.65%
Jan 27, 2025
Initiates: Buy
Price Target: $22
Current: $0.33
Upside: +6,570.71%
Jan 22, 2025
Maintains: Buy
Price Target: $10
Current: $3.08
Upside: +224.68%
Jan 22, 2025
Maintains: Buy
Price Target: $15
Current: $10.13
Upside: +48.08%
Jan 21, 2025
Maintains: Buy
Price Target: $25
Current: $3.54
Upside: +606.21%
Jan 21, 2025
Maintains: Buy
Price Target: $15
Current: $1.57
Upside: +855.41%
Jan 17, 2025
Maintains: Buy
Price Target: $12
Current: $0.45
Upside: +2,565.48%
Jan 15, 2025
Maintains: Buy
Price Target: $9
Current: $0.81
Upside: +1,005.65%
Jan 14, 2025
Maintains: Buy
Price Target: $6
Current: $1.16
Upside: +417.24%
Jan 13, 2025
Maintains: Buy
Price Target: $128 → $16
Current: $3.46
Upside: +362.43%
Jan 13, 2025
Maintains: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Jan 13, 2025
Initiates: Buy
Price Target: $9
Current: $3.13
Upside: +187.54%
Jan 8, 2025
Maintains: Buy
Price Target: $32
Current: $2.92
Upside: +995.89%
Jan 8, 2025
Maintains: Buy
Price Target: $21
Current: $4.60
Upside: +356.52%
Jan 6, 2025
Initiates: Buy
Price Target: $23
Current: $6.30
Upside: +265.08%
Dec 27, 2024
Maintains: Buy
Price Target: $16
Current: $1.13
Upside: +1,322.22%
Aug 13, 2024
Maintains: Buy
Price Target: $6
Current: $1.17
Upside: +412.82%
Feb 28, 2024
Initiates: Buy
Price Target: $9,600
Current: $9.17
Upside: +104,589.20%
Aug 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.45
Upside: -
Feb 6, 2023
Maintains: Buy
Price Target: $16,002 → $45,990
Current: $2.04
Upside: +2,254,311.76%
Jan 30, 2023
Initiates: Buy
Price Target: $120
Current: $0.39
Upside: +30,426.58%
Jan 6, 2023
Initiates: Buy
Price Target: $6
Current: $0.12
Upside: +4,908.35%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.31
Upside: -
Sep 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.09
Upside: -
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.53
Upside: -
Mar 17, 2021
Downgrades: Neutral
Price Target: $40
Current: $0.77
Upside: +5,065.96%
Nov 6, 2020
Maintains: Buy
Price Target: $33 → $32
Current: $1.07
Upside: +2,890.65%
Jul 28, 2020
Downgrades: Neutral
Price Target: $720 → $480
Current: $2.43
Upside: +19,653.09%
Jun 15, 2018
Terminates: Sell
Price Target: n/a
Current: $5.76
Upside: -
Mar 6, 2018
Downgrades: Hold
Price Target: n/a
Current: $2.40
Upside: -
Aug 17, 2017
Maintains: Buy
Price Target: $120 → $135
Current: $1.73
Upside: +7,703.47%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.59
Upside: -